Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
1000 participants
OBSERVATIONAL
2010-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
NCT01201707
Venous Sinus Stenting With the River Stent in IIH
NCT03556085
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
NCT01407809
Registry of Emergent Large VeSsel OCclUsion DuE to IntraCranial AtherosclerosiS
NCT05403593
Cerebrospinal Fluid (CSF) Drainage Study
NCT01420978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CNS draining vein abnormalities
venous angioplasty
catheter venous angioplasty via femoral vein approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
venous angioplasty
catheter venous angioplasty via femoral vein approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hubbard Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David R Hubbard, M.D.
Role: STUDY_CHAIR
Hubbard Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vascular Access Center of Downey
Downey, California, United States
North County Radiology
Oceanside, California, United States
Vascular Access Care of Atlanta
Atlanta, Georgia, United States
Columbia endovascular Associates
New York, New York, United States
Valley Endovascular Associates
Poughkeepsie, New York, United States
Dayton Interventional Radiology
Dayton, Ohio, United States
Utah Valley Interventional Associates
Provo, Utah, United States
Utah Vascular Clinic
Salt Lake City, Utah, United States
Vascular Access Center of Seattle
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCSVI Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.